CRS Clinical Research Services Management GmbH

The medical center is at the forefront of research in plaque psoriasis, focusing on innovative treatments for patients with moderate to severe conditions affecting special areas. The ongoing studies aim to enhance the efficacy and safety of new therapeutic agents, providing relief and improving the quality of life for those affected by this chronic skin condition.

• Innovative therapeutic approaches
• Focus on special areas of involvement
• Improvement in patient quality of life

Through rigorous clinical trials, the center contributes significantly to the understanding and management of plaque psoriasis, offering hope for more effective treatments.

Specializing in the treatment of moderate-to-severe pruritus associated with notalgia paresthetica, the center is dedicated to exploring the efficacy of novel oral medications. By evaluating different dosages and their impact on itch intensity, the research aims to identify optimal treatment strategies that can significantly alleviate symptoms for patients.

• Assessment of novel oral medications
• Focus on reducing itch intensity
• Optimization of treatment strategies

The center's commitment to advancing the understanding of pruritus and its management underscores its role as a leader in dermatological research and patient care.